Preliminary development of a new individualised questionnaire measuring quality of life in older men with age-related hormonal decline: The A-RHDQoL

Health and Quality of Life Outcomes

Volumn 1, Issue , 2003, Pages

  McMillan, Carolyn V ^a   Bradley, Clare ^a   Giannoulis, Manthos ^b   Martin, Finbarr ^b   Sönksen, Peter H ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

A RHDQoL; Age related hormonal decline; Quality of life

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C; TESTOSTERONE; HUMAN GROWTH HORMONE;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; ENDURANCE; ENERGY; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR; STATISTICAL ANALYSIS; VALIDATION PROCESS; BLOOD; CROSS-SECTIONAL STUDY; HEALTH SURVEY; INSTRUMENTATION; MEN'S HEALTH; MIDDLE AGED; PHYSIOLOGY; REPRODUCIBILITY; VALIDATION STUDY;

AGED; AGED, 80 AND OVER; AGING; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; HEALTH STATUS INDICATORS; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; MALE; MEN'S HEALTH; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TESTOSTERONE;

EID: 4243153928     PISSN: 14777525     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7525-1-51     Document Type: Article

References (43)

1. United Nations: The world population prospects: the 2000 revision. [http://www.un.org/esa/population/publications/wpp2000/ highlights.pdf]. (accessed June 2003)
2. Hermann M and Berger P: Hormone replacement in the aging male? Exp Gerontol 1999, 34:923-933.
3. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA and Bain RP: Impaired growth-hormone secretion in the adult population - Relation to age and adiposity. J Clin Invest 1981, 67:1361-1369.
4. Vermeulen A: Clinical review 24: Androgens in the aging male. J Clin Endocrinol Metab 1991, 73:221-224.
5. Carroll PV, Christ ER and Growth Hormone Research Society Scientific Committee: Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J Clin Endocrinol Metab 1998, 83:382-395.
6. Colao A, di Somma C, Cuocolo A, Spinelli L, Tedesco N, Pivonello R, Bonaduce D, Salvatore M and Lombardi G: Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (gh) replacement in young adult patients with gh deficiency. J Clin Endocrinol Metab 2001, 86:1874-1881.
7. Howell S and Shalet S: Testosterone deficiency and replacement. Horm Res 2001, 56(Suppl 1):86-92.
8. Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A, Santanna J, Loh L, Lenrow DA, Holmes JH, Kapoor SC, Atkinson LE and Strom BL: Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 2000, 85:2670-2677.
9. Martin FC: Frailty and the somatopause. Growth Horm IGF Res 1999, 9:3-10.
10. Anawalt BD and Merriam GR: Neuroendocrine aging in men. Andropause and somatopause. Endocrinol Metab Clin North Am 2001, 30:647-669.
11. Welle S, Thornton C, Statt M and McHenry B: Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old. J Clin Endocrinol Metab 1996, 81:3239-3243.
12. Rudman D, Feller AG, Cohn L, Shetty KR, Rudman IW and Draper MW: Effects of human growth-hormone on body-composition in elderly men. Horm Res 1991, 36:73-81.
13. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Holmes JH, Dlewati A, Staley J, Santanna J, Kapoor SC, Attie MF, Haddad JG Jr and Strom BL: Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 1999, 84:1966-1972.
14. Kenny AM, Prestwood KM, Gruman CA, Marcello KM and Raisz LG: Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 2001, 56:M266-272.
15. Blackman MR, Sorkin JD, Munzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE, Jayme J, O'Connor KG, Christmas C, Tobin JD, Stewart KJ, Cottrell E, St Clair C, Pabst KM and Harman SM: Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 2002, 288:2282-2292.
16. Giannoulis MG, McMillan CV, Bradley C, Breen L, Umpleby M, Sönksen PH and Martin F: Effects of growth hormone administration (by individually tailored dose titration) and/ or testosterone on body composition, physical performance and quality of life in healthy elderly men. Presentation at the Endocrine Society's 85th annual meeting 2003.
17. Barrett-Connor E, Goodman-Gruen D and Patay B: Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab 1999, 84:3681-3685.
18. Barrett-Connor E, Von Muhlen DG and Kritz-Silverstein D: Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J Clin Endocrinol Metab 1999, 84:573-577.
19. Wilson DE, Kaidbey K, Boike SC and Jorkasky DK: Use of topical corticosteroid pretreatment to reduce the incidence and severity of skin reactions associated with testosterone transdermal therapy. Clin Ther 1998, 20:299-306.
20. Ware JE and Sherbourne CD: The MOS 36-Item Short-Form Health Survey (SF-36). 1. Conceptual framework and item selection. Med Care 1992, 30:473-483.
21. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ and Strom BL: Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999, 84:2647-2653.
22. Kenny AM, Bellantonio S, Gruman CA, Acosta RD and Prestwood KM: Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 2002, 57:M321-M325.
23. Reddy P, White CM, Dunn AB, Moyna NM and Thompson PD: The effect of testosterone on health-related quality of life in elderly males - a pilot study. J Clin Pharm Ther 2000, 25:421-426.
24. Dupuy HJ: The Psychological General Well-being Index (PGWB). In Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies Edited by: Wenger NK, Mattson ME, Furburg CD, Elinson J. New York: Le Jacq Publishing Inc; 1984.
25. Bradley C: Importance of differentiating health status from quality of life. Lancet 2001, 357:7-8.
26. McGee HM, O'Boyle CA, Hickey A, O'Malley KM and Joyce CRB: Assessing the quality of life of the individual: The SEIQoL with a healthy and a gastroenterology unit population. Psychol Med 1991, 21:749-759.
27. Bradley C, Todd C, Gorton T, Symonds E, Martin A and Plowright R: The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999, 8:79-91.
28. Bradley C and Speight J: Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab Res Rev 2002, 18(Suppl 3):S64-S69.
29. Mitchell J and Bradley C: Design of the MacDQoL individualised measure of the impact of macular disease on quality of life. Qual Life Res 2002, 11:302.
30. McMillan C and Bradley C: A comparison of the psychometric properties of quality of life and related measures (GWBI, WBQ12, NHP, SF-36 and HDQoL) for use in research into adult growth hormone deficiency (GHD) [abstract]. Qual Life Res 2000, 9:1352.
31. Bradley C: Achieving accessibility with quality: questionnaire measurement of condition-specific individualised quality of life. Proceedings of the British Psychological Society 1999, 7:143.
32. McMillan CV, Bradley C, Gibney J, Healy ML, Russell-Jones DL and Sönksen PH: Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency. Clin Endocrinol (Oxf) 2003, 59:467-475.
33. McMillan CV: A psychometric evaluation of measures of quality of life and related health outcomes in adults with growth hormone deficiency. PhD Thesis Royal Holloway, University of London, Psychology Department; 2001.
34. Bradley C: The Well-being Questionnaire. In Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice Edited by: Bradley C. Chur Switzerland: Harwood Academic Publishers; 1994:9-109.
35. Bradley C: The12-item Well-being Questionnaire: Origins, current stage of development, and availability. Diab Care 2000, 23:875.
36. Tabachnik BG and Fidell LS: Using Multivariate Statistics 2nd edition. New York: Harper and Row; 1989.
37. Tabachnik BG and Fidell LS: Using Multivariate Statistics 1st edition. New York: Harper and Row; 1983.
38. Todd C and Bradley C: Evaluating the design and development of psychological scales. In Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice Edited by: Bradley C. Chur Switzerland: Harwood Academic Publishers; 1994:15-42.
39. Nunnally JC and Bernstein IH: Psychometric Theory 3rd edition. New York: McGraw-Hill, Inc; 1994.
40. Kline P: A Handbook of Test Construction London: Routledge; 1993.
41. Kline P: An Easy Guide to Factor Analysis London: Routledge; 1994.
42. Holm S: A simple sequentially rejective multiple test procedure. Scand J Stat 1979, 6:65-70.
43. Mitchell J and Bradley C: Psychometric evaluation of the 12- item Well-being Questionnaire for use with people with macular disease. Qual Life Res 2001, 10:465-473.